Cytokines such as IL-12 and IL-2 are promising cancer vaccine immunostimulants due to their ability to enhance tumor-specific T cell proliferation and activation, promoting cytotoxic responses and Th1 polarization [152, 159]. The gene discussed is IL2; the disease is neoplasm.